News

DM Clinical Research Expands with New Clinical Trial Site

DM Clinical Research Expands with New Clinical Trial Site

DM Clinical Research and Physician Partners to Launch an Embedded Clinical Trial Site

DM Clinical Research has announced a new collaboration with Dr. Jai Munjampalli and Dr. Sara Samreena to open an embedded clinical trial site within their practices. The goal is straightforward: make it easier for patients to consider and join research studies while receiving care from the clinicians they already know. The site will live inside the practices of Dr. Munjampalli and Dr. Samreena, bringing research closer to everyday care in neurology, pain management, and sleep medicine.

Bringing Trials Closer to Care

This partnership expands DM Clinical Research’s reach so more patients can access studies tied to innovative treatments. It also reflects the organization’s ongoing commitment to opening doors across neurologic conditions, pain management, and sleep disorders. By integrating research into the physicians’ existing clinics, patients can learn about and enroll in trials where they’re already getting care, which helps reduce delays and lowers common barriers to participation.

The Physicians Leading the Site

Dr. Jai Munjampalli brings 13 years of clinical research experience and 7 years of service as a practicing physician. After medical school, he completed extensive training in neurology and interventional pain management. He treats complex conditions such as migraines, chronic headaches, and a range of pain syndromes. Working alongside him is Dr. Sara Samreena, a family medicine physician with double certification in sleep medicine. Together, their complementary expertise gives the new site a strong clinical foundation.

A Combined Focus: Neurology, Pain, and Sleep

For nine years, Dr. Samreena has focused on outpatient sleep medicine, diagnosing and managing common sleep disorders, including insomnia and sleep apnea. Her work pairs naturally with Dr. Munjampalli’s focus in neurology and pain. Placing these disciplines under one embedded research effort creates a practical path for evaluating symptoms, discussing study options, and coordinating follow-up in one place. Patients can expect a cohesive approach that connects everyday care with research opportunities.

Strategy and Next Steps

The new site fits into DM Clinical Research’s broader plan to build a nationwide network of clinical trial locations. The organization remains committed to designing and conducting diverse, inclusive trials that serve a wide range of therapeutic needs. Partnering with experienced physicians like Dr. Munjampalli and Dr. Samreena advances that plan and aligns with DM Clinical Research’s mission to innovate and improve outcomes through thoughtfully run clinical trials.

Patient Care at the Center

CEO Mohammad Millwala described the collaboration as a key step for DM Clinical Research. By tapping into the established strengths of these practices, DM Clinical Research brings research capabilities directly to the patient community. The aim is clear: support progress in medical research while keeping patient care—timely, informed, and respectful—at the heart of every decision.

About DM Clinical Research

DM Clinical Research is a national clinical trial network headquartered in Houston, Texas. Founded in 2006, it includes 24 dedicated research centers that span a broad mix of therapeutic areas. The organization has been recognized with the 2023 Best Clinical Trial Network Vaccine Industry Excellence Award and the 2022 Excellence in Patient Centricity Award—acknowledgments that reflect its focus on quality research and a patient-first approach.

Frequently Asked Questions

What is the main goal of the partnership?

The collaboration will establish an embedded clinical trial site inside the partners’ practices, making it easier for patients to access studies in neurology, pain management, and sleep medicine.

Who are the partners involved in this initiative?

The site is being launched with Dr. Jai Munjampalli, a neurologist with expertise in interventional pain management, and Dr. Sara Samreena, a family medicine physician with double certification in sleep medicine.

How will patients benefit from this new site?

Patients can learn about and join relevant clinical trials where they already receive care, which can streamline referrals, reduce extra steps, and connect them with potential new treatment options.

What awards has DM Clinical Research received?

DM Clinical Research has received the 2023 Best Clinical Trial Network Vaccine Industry Excellence Award and the 2022 Excellence in Patient Centricity Award.

Where is DM Clinical Research headquartered?

DM Clinical Research is headquartered in Houston, Texas.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Diwali Celebration in Chicago Honors Indian Community

Updated Category News Views 142

Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...

Continue Reading
AI Governance: Banks' Secret to Successful Scaling

Updated Category News Views 90

AI in Banking: Cautious Steps Forward Banks aren't exactly racing with AI; they're inching forward. With AI agents entering the picture, you'd think the buzz would be about groundbreaking deployments. Instead, the story here is more about banks holding their cards close to the vest. Agentic AI, with its ability to plan and act without a human babysitter at every step, is...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 93

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
POWERCHINA's Clean Energy Initiatives at COP31 Spotlighted

Updated Category News Views 136

A Global Push for Clean Energy: POWERCHINA's Role Picture this: a bustling global scene at the United Nations Climate Change Conference, COP31, in Antalya, with leaders huddling over the future of our planet's energy. Meanwhile, Power Construction Corporation of China (POWERCHINA) is out there in the trenches, muscling through the monumental task of turning ambitious...

Continue Reading
Palatin Prepares for FY27 Results Amid Market Curiosity

Updated Category News Views 51

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Continue Reading
Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 28

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 107

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 79

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
Secrets to Selecting Fresh Seafood for Your Boil

Updated Category News Views 85

Navigating the Waters of Seafood Quality When it comes to throwing together a proper Louisiana seafood boil, your whole evening could sink or swim based on seafood freshness. Jonathan Sumich, a grocery veteran from Oak Point Fresh Market, spills the beans on picking the cream of the crop. Plan it right, and you’re the hero of the feast. Ignore these tips, and you might...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Class Action Lawsuit Involving Elevance Health

Updated Category News Views 316

Investigating the Class Action Lawsuit Against Elevance Health Investors should be aware of the ongoing class action lawsuit involving Elevance Health, Inc. (NYSE: ELV). This lawsuit has been initiated to address significant concerns regarding false and misleading statements made by the company. The deadline for potential lead plaintiffs to participate is approaching, and...

Continue Reading
Enhancing Patient Care through Cloud Imaging Solutions

Updated Category News Views 204

Introduction to Unified Imaging Services In a groundbreaking development, Sweden's Region Stockholm is set to transform its medical imaging landscape. By utilizing the innovative enterprise imaging solution provided by Sectra, a leader in medical imaging IT, all hospitals within the region will transition to a holistic cloud service. This monumental shift aims to enhance...

Continue Reading
G2 Goldfields Unveils Exciting Drilling Results at OKO

Updated Category News Views 113

G2 Goldfields Expands Mineral Resources at OKO G2 Goldfields Inc. (“G2”) (TSX: GTWO; OTCQX: GUYGF) has some exciting updates to share about its exploration activities at the vast 27,719-acre OKO-AREMU gold project. The company recently provided a significant update on their Mineral Resource Estimate (MRE), which now shows a remarkable total of 922,000 ounces of gold...

Continue Reading
Citi Lowers Charles River Labs Rating Amid Revenue Challenges

Updated Category News Views 131

Charles River Laboratories Faces Downgrade from Citi Charles River Laboratories International Inc. (NYSE: CRL), recognized for its pivotal role in preclinical and clinical laboratory services, has recently encountered a downgrade in its stock rating from the prominent firm Citi. This adjustment is a significant indicator of the shifting dynamics in the pharmaceutical...

Continue Reading
Banco Comercial Português Reports Promising 2024 Earnings

Updated Category News Views 165

Banco Comercial Português, S.A. Reports Its 2024 Earnings Banco Comercial Português, S.A., one of the major banking institutions, has unveiled its consolidated earnings for the year 2024. The financial results highlight a strong performance, indicating the bank's resilience and adaptability in a competitive marketplace. Overview of Earnings The bank exhibited robust...

Continue Reading